Published in Aliment Pharmacol Ther on September 01, 2005
A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | NCT02046694
Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD. J Crohns Colitis (2010) 0.92
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment. Expert Rev Gastroenterol Hepatol (2014) 0.90
Inflammatory bowel disease of the elderly: a wake-up call. Gastroenterol Hepatol (N Y) (2008) 0.89
Thiopurines in inflammatory bowel disease revisited. World J Gastroenterol (2013) 0.88
Observations on the use of allopurinol in combination with azathioprine or mercaptopurine. Aliment Pharmacol Ther (2005) 0.85
Therapeutic drug monitoring in patients with inflammatory bowel disease. World J Gastroenterol (2014) 0.84
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease. World J Gastroenterol (2011) 0.82
Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2008) 0.80
What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails? World J Gastroenterol (2014) 0.79
Use of allopurinol with low-dose 6-mercaptopurine in inflammatory bowel disease to achieve optimal active metabolite levels: a review of four cases and the literature. Can J Gastroenterol (2008) 0.79
Optimizing therapy with 6-mercaptopurine and azathioprine: to measure or not to measure? Therap Adv Gastroenterol (2010) 0.78
Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations. Eur J Clin Pharmacol (2013) 0.78
Use of thiopurines in inflammatory bowel disease: Safety issues. World J Gastrointest Pharmacol Ther (2014) 0.77
Medical management of Crohn's disease. Clin Colon Rectal Surg (2007) 0.76
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction. Dig Dis Sci (2011) 0.76
Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease. Clin Transl Gastroenterol (2016) 0.75
Start low, go slow, but don't go this way yet. Can J Gastroenterol (2008) 0.75
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment. Eur J Clin Pharmacol (2015) 0.75
New keys to maintenance treatment in ulcerative colitis. Dig Dis (2010) 0.75
Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine. Br J Pharmacol (2011) 0.75
Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective. World J Gastroenterol (2016) 0.75
Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series. BMC Gastroenterol (2013) 0.75
A Personalized Approach to Managing Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2016) 0.75
Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone. Inflamm Bowel Dis (2017) 0.75
Monitoring thiopurine metabolites in inflammatory bowel disease. Frontline Gastroenterol (2016) 0.75
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes. Nature (1987) 4.40
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med (2001) 3.55
The retained surgical sponge. Ann Surg (1996) 3.46
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med (2000) 2.78
Nucleotide sequence and expression of the gene encoding the EcoRII modification enzyme. Nucleic Acids Res (1987) 2.68
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology (1989) 2.66
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis (1999) 2.55
The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates. Am J Public Health (1999) 2.52
Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis (2006) 2.45
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol (2001) 2.39
Hospitalization in the Program of All-Inclusive Care for the Elderly (PACE): rates, concomitants, and predictors. J Am Geriatr Soc (2000) 2.38
Capsule endoscopy structured terminology (CEST): proposal of a standardized and structured terminology for reporting capsule endoscopy procedures. Endoscopy (2005) 2.34
Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci U S A (1996) 2.30
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology (1999) 2.25
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Purification and properties of the Escherichia coli deoxyribonucleic acid-unwinding protein. Effects on deoxyribonucleic acid synthesis in vitro. J Biol Chem (1974) 2.22
Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother (2001) 2.22
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial. Gastroenterology (1999) 2.15
Markers for primary care: missed opportunities to immunize and screen for lead and tuberculosis by private physicians serving large numbers of inner-city Medicaid-eligible children. Pediatrics (1996) 2.14
3,4-dihydroxyphenylethylamine beta-hydroxylase. Physical properties, copper content, and role of copper in the catalytic acttivity. J Biol Chem (1965) 2.13
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease. Aliment Pharmacol Ther (2013) 2.12
3-(3-amino-3-carboxy-n-propyl)uridine. The structure of the nucleoside in Escherichia coli transfer ribonucleic acid that reacts with phenoxyacetoxysuccinimide. Biochemistry (1974) 2.06
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. Gastroenterology (1993) 2.03
Characterization of Salmonella enterica serotype newport isolated from humans and food animals. J Clin Microbiol (2003) 2.02
Congenital left aortic sinus-left ventricle fistula and review of aortocardiac fistulas. Ann Thorac Surg (1977) 2.01
Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol (1999) 1.90
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates. Appl Environ Microbiol (2001) 1.82
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology (1998) 1.71
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol (1993) 1.70
A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil Steril (1984) 1.68
Kinetic mapping of the antibody combining site by chemical relaxation spectrometry. Biochemistry (1974) 1.68
The inhibition of DNA(cytosine-5)methylases by 5-azacytidine. The effect of azacytosine-containing DNA. Mol Pharmacol (1981) 1.62
Gestational diabetes mellitus. A survey of perinatal complications in the 1980s. Diabetes (1991) 1.61
Transfer of the methyl group from N5-methyltetrahydrofolates to homocysteine in Escherichia coli. Biochem J (1964) 1.59
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
Differences in the locational attainment of immigrant and native-born households with children in New York City. Demography (2001) 1.56
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Antimicrobial resistance and genetic relatedness among Salmonella from retail foods of animal origin: NARMS retail meat surveillance. Foodborne Pathog Dis (2006) 1.52
Binding of the EcoRII methylase to azacytosine-containing DNA. Nucleic Acids Res (1986) 1.51
HIV transmission through donor artificial insemination. JAMA (1995) 1.49
Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J Protozool (1984) 1.46
Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci U S A (1992) 1.44
A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy (2005) 1.43
Isolation and characterization of mitochondrial DNA from Drosophila melanogaster. J Cell Biol (1973) 1.43
Surgical results of intrathoracic gastric volvulus complicating hiatal hernia. Br J Surg (1990) 1.43
Improved specificity of myoglobin plus carbonic anhydrase assay versus that of creatine kinase-MB for early diagnosis of acute myocardial infarction. Ann Emerg Med (1996) 1.42
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity. Gastroenterology (2000) 1.40
The irreversible binding of azacytosine-containing DNA fragments to bacterial DNA(cytosine-5)methyltransferases. J Biol Chem (1985) 1.40
Periapical health and treatment quality assessment of root-filled teeth in two Canadian populations. Int Endod J (2003) 1.40
Genetic testing for cancer predisposition--an ongoing debate. Lancet Oncol (2000) 1.39
Association between milk production, somatic cell count and bacterial dermatoses in three dairy cattle herds. Aust Vet J (2000) 1.39
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates. Am J Psychiatry (1989) 1.38
A successful technique for the treatment of diabetic neurotrophic ulcers. J Am Podiatr Med Assoc (1992) 1.38
Effects of sodium lactate infusion on cisternal lactate and carbon dioxide levels in nonhuman primates. Am J Psychiatry (1992) 1.38
The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol (1998) 1.35
Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States. J Allergy Clin Immunol (1992) 1.34
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci (1989) 1.34
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut (1997) 1.32
Effect of the vaccines for children program on inner-city neighborhood physicians. Arch Pediatr Adolesc Med (1997) 1.32
Polycystic kidneys associated with malformations of the brain, polydactyly, and other birth defects in newborn sibs. A lethal syndrome showing the autosomal-recessive pattern of inheritance. J Med Genet (1971) 1.32
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol (2000) 1.31
Periodontal healing of replanted dog teeth stored in Viaspan, milk and Hank's balanced salt solution. Endod Dent Traumatol (1992) 1.30
Endodontic retreatment--case selection and technique. Part 2: Treatment planning for retreatment. J Endod (1988) 1.29
Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology (1986) 1.26
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. Ophthalmology (2007) 1.25
Evaluation of Community Care Network (CCN) system in a rural health care setting. Proc Annu Symp Comput Appl Med Care (1995) 1.24
Impact of financial incentives on documented immunization rates in the inner city: results of a randomized controlled trial. Ambul Pediatr (2002) 1.23
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol (2005) 1.22
Physiologic correction of transposition of the great arteries. Indications for and results of operation in 32 patients. Circulation (1971) 1.22
Corynebacterium pseudotuberculosis infection in Israeli dairy cattle. Epidemiol Infect (2003) 1.21
Structured terminology for capsule endoscopy: results of retrospective testing and validation in 766 small-bowel investigations. Endoscopy (2005) 1.20
Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis. Aliment Pharmacol Ther (2003) 1.20
Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer (1988) 1.20
Clostridium difficile culture-positive toxin-negative diarrhea. Am J Gastroenterol (1986) 1.20
Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N Engl J Med (1984) 1.19
Experiences with ARTEMIS--an Internet-based telemedicine system. Proc AMIA Annu Fall Symp (1997) 1.18
The effect of 5-azacytidine on E. coli DNA methylase. Biochem Biophys Res Commun (1979) 1.17
Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology (2007) 1.16
New York City physicians serving high volumes of Medicaid children: who are they and how do they practice? Inquiry (1995) 1.15
Regulation of EcoRII methyltransferase: effect of mutations on gene expression and in vitro binding to the promoter region. Nucleic Acids Res (1994) 1.15
Acylation of transfer ribonucleic acid with the N-hydroxysuccinimide ester of phenoxyacetic acid. Biochemistry (1972) 1.15
Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf (2000) 1.15
The parasitic ecology of the rodent mite, Myobia musculi. III. Lesions in certain host strains. Lab Anim Sci (1976) 1.15
Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis. Oncogene (2011) 1.14
The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol (1987) 1.14
Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol (2000) 1.14
Abnormal precipitation of oxyhemoglobin S by mechanical shaking. Proc Natl Acad Sci U S A (1974) 1.14
Identification of a highly conserved domain in the EcoRII methyltransferase which can be photolabeled with S-adenosyl-L-[methyl-3H]methionine. Evidence for UV-induced transmethylation of cysteine 186. J Biol Chem (1991) 1.14